Ad is loading...
MDEGX
Price
$14.06
Change
+$0.08 (+0.57%)
Updated
Nov 22 closing price
RNPEX
Price
$64.39
Change
+$0.26 (+0.41%)
Updated
Nov 22 closing price
Ad is loading...

MDEGX vs RNPEX

Header iconMDEGX vs RNPEX Comparison
Open Charts MDEGX vs RNPEXBanner chart's image
BlackRock Unconstrained Equity Inv A
Price$14.06
Change+$0.08 (+0.57%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R4
Price$64.39
Change+$0.26 (+0.41%)
VolumeN/A
CapitalizationN/A
MDEGX vs RNPEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MDEGX vs. RNPEX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDEGX is a Buy and RNPEX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 144B vs. MDEGX (1.38B). RNPEX pays higher dividends than MDEGX: RNPEX (0.83) vs MDEGX (0.00). MDEGX was incepted earlier than RNPEX: MDEGX (19 years) vs RNPEX (23 years). MDEGX is a more actively managed with annual turnover of: 27.00 vs. RNPEX (17.00). RNPEX has a lower initial minimum investment than MDEGX: RNPEX (250) vs MDEGX (1000). RNPEX annual gain was more profitable for investors over the last year : 18.38 vs. MDEGX (14.31). RNPEX return over 5 years is better than : 41.31 vs. MDEGX (-4.29).
MDEGXRNPEXMDEGX / RNPEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years23 years-
Gain YTD8.73917.32950%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.38B144B1%
Annual Yield % from dividends0.000.83-
Returns for 1 year14.3118.3878%
Returns for 3 years-5.83-6.9784%
Returns for 5 years-4.2941.31-10%
Returns for 10 years-6.0668.16-9%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRUG35.332.95
+9.11%
Bright Minds Biosciences
HWC59.972.07
+3.58%
Hancock Whitney Corp
ECPG49.141.10
+2.29%
Encore Capital Group
BR230.242.77
+1.22%
Broadridge Financial Solutions
CTXR0.13-0.03
-18.96%
Citius Pharmaceuticals